Huntington National Bank’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52 | Hold |
1
| – | – | ﹤0.01% | 2877 |
|
|
2025
Q4 | $52 | Hold |
1
| – | – | ﹤0.01% | 2799 |
|
|
2025
Q3 | $52 | Hold |
1
| – | – | ﹤0.01% | 2876 |
|
|
2025
Q2 | $52 | Hold |
1
| – | – | ﹤0.01% | 2912 |
|
|
2025
Q1 | $52 | Hold |
1
| – | – | ﹤0.01% | 2944 |
|
|
2024
Q4 | $52 | Hold |
1
| – | – | ﹤0.01% | 2970 |
|
|
2024
Q3 | $52 | Hold |
1
| – | – | ﹤0.01% | 2964 |
|
|
2024
Q2 | $52 | Hold |
1
| – | – | ﹤0.01% | 2929 |
|
|
2024
Q1 | $52 | Hold |
1
| – | – | ﹤0.01% | 2762 |
|
|
2023
Q4 | $52 | Hold |
1
| – | – | ﹤0.01% | 2670 |
|
|
2023
Q3 | $52 | Hold |
1
| – | – | ﹤0.01% | 2650 |
|
|
2023
Q2 | $52 | Hold |
1
| – | – | ﹤0.01% | 2620 |
|
|
2023
Q1 | $52 | Hold |
1
| – | – | ﹤0.01% | 2458 |
|
|
2022
Q4 | $52 | Sell |
1
-277
| -100% | -$14.4K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $14K | Sell |
278
-694
| -71% | -$28.7K | ﹤0.01% | 1436 |
|
|
2022
Q2 | $24K | Buy |
972
+875
| +902% | +$19.3K | ﹤0.01% | 1265 |
|
|
2022
Q1 | $2K | Buy |
97
+26
| +37% | +$731 | ﹤0.01% | 1936 |
|
|
2021
Q4 | $3K | Buy |
+71
| New | +$2.49K | ﹤0.01% | 1856 |
|
Huntington National Bank's CCXI Position: Q1 2026 in Review
Huntington National Bank held its ChemoCentryx, Inc. (CCXI) position steady in Q1 2026 at 1 share worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #2877.
Huntington National Bank first reported a position in CCXI in Q4 2021 and has held it in 18 quarters since. The position peaked at $24K in Q2 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q1 2026.
- Huntington National Bank held 1 share of ChemoCentryx, Inc. worth $52 as of Q1 2026.
- Huntington National Bank left its ChemoCentryx, Inc. share count unchanged in Q1 2026.
- ChemoCentryx, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2877 holding.
- Huntington National Bank first reported a position in ChemoCentryx, Inc. in Q4 2021 and has held it in 18 quarters since.
- Huntington National Bank's ChemoCentryx, Inc. position peaked at $24K in Q2 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.